BAPS collective review: chronic inflammatory bowel disease

Area of Science:

• Pediatric Gastroenterology
• Inflammatory Bowel Disease Research
• Clinical Pediatrics

Background:

• Chronic inflammatory bowel disease (CIBD) presents unique challenges in children.
• Early diagnosis and management are crucial for long-term outcomes in pediatric IBD.
• Growth failure is a significant concern in pediatric Crohn's disease.

Purpose of the Study:

• To review the clinical characteristics, diagnostic methods, and outcomes of pediatric CIBD cases.
• To analyze the surgical management and long-term disease course in children with Crohn's disease and ulcerative colitis.
• To assess the impact of CIBD on growth and overall health in pediatric patients.

Main Methods:

• Retrospective review of 153 pediatric CIBD cases diagnosed between 1970-1979.
• Analysis of diagnostic delays, presenting symptoms, and treatment interventions.
• Evaluation of surgical outcomes, disease progression, and mortality rates at follow-up.

Main Results:

• Mean diagnosis ages were 10.5 years for Crohn's disease (CD) and 8.8 years for ulcerative colitis (UC), with diagnostic delays of 16.3 and 9.3 months, respectively.
• Growth failure was prominent in CD (35.7% at follow-up).
• Surgery was required in 57% of CD cases and 26% of UC cases, with high rates of reoperation and persistent disease (65% CD, 52% UC) at mean 6-year follow-up.

Conclusions:

• Pediatric CIBD, particularly CD, is associated with significant growth impairment and a substantial need for surgical intervention.
• Delayed diagnosis and the chronic nature of the disease contribute to ongoing morbidity in children.
• Effective long-term management strategies are essential for improving outcomes in pediatric IBD patients.